• LAST PRICE
    0.6475
  • TODAY'S CHANGE (%)
    Trending Up0.0075 (1.1720%)
  • Bid / Lots
    0.6400/ 45
  • Ask / Lots
    0.6550/ 806
  • Open / Previous Close
    0.6500 / 0.6400
  • Day Range
    Low 0.6400
    High 0.6599
  • 52 Week Range
    Low 0.5528
    High 2.5300
  • Volume
    9,814
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.64
TimeVolumeBLRX
09:32 ET5280.65
09:39 ET12000.64
09:41 ET1000.65
09:45 ET35000.64
09:54 ET1910.6549
09:57 ET1360.647501
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBLRX
BioLine RX Ltd
53.8M
-0.8x
---
United StatesLVTX
LAVA Therapeutics NV
54.9M
-1.9x
---
United StatesCUE
Cue Biopharma Inc
65.2M
-1.2x
---
United StatesLPCN
Lipocine Inc
57.2M
-6.6x
---
United StatesDYAI
Dyadic International Inc
57.6M
-7.0x
---
United StatesKRON
Kronos Bio Inc
62.5M
-0.5x
---
As of 2024-06-18

Company Information

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Contact Information

Headquarters
Modi'in Technology Park 2 HaMa'ayan StreetMODIIN, Israel 7177871
Phone
---
Fax
---

Executives

Chairman of the Board
Aharon Schwartz
Chief Executive Officer
Philip Serlin
Chief Financial Officer
Mali Zeevi
Vice President - Development
Ella Sorani
Vice President-Clinical & Medical Affairs
Abi Vainstein-Haras

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$53.8M
Revenue (TTM)
$11.7M
Shares Outstanding
79.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.53
EPS
$-0.76
Book Value
$0.18
P/E Ratio
-0.8x
Price/Sales (TTM)
4.6
Price/Cash Flow (TTM)
---
Operating Margin
-391.76%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.